Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Cardinal Health ( (CAH) ) has provided an announcement.
On April 30, 2026, Cardinal Health reported third-quarter fiscal 2026 revenue of $60.9 billion, up 11% year on year, driven largely by growth in brand and specialty pharmaceutical sales to existing customers. GAAP operating earnings fell 30% to $509 million and GAAP EPS declined 20% to $1.69, mainly due to a $184 million goodwill impairment in the Navista & ION unit tied to changes in business risk and discount rates.
Non-GAAP results were markedly stronger, with operating earnings rising 18% to $956 million and diluted EPS climbing 35% to $3.17, supported by higher segment profits, a lower non-GAAP tax rate and a reduced share count. The Pharmaceutical and Specialty Solutions segment delivered 11% revenue growth to $56.1 billion and an 18% profit increase to $784 million, while Global Medical Products and Distribution revenue was flat and segment profit dropped 36% to $25 million due to tariff headwinds, and the company raised and narrowed its fiscal 2026 non-GAAP EPS guidance and continued capital returns through $1.0 billion of share repurchases and debt reduction.
The most recent analyst rating on (CAH) stock is a Buy with a $256.00 price target. To see the full list of analyst forecasts on Cardinal Health stock, see the CAH Stock Forecast page.
Spark’s Take on CAH Stock
According to Spark, TipRanks’ AI Analyst, CAH is a Neutral.
The score is supported primarily by strong earnings momentum and raised FY26 guidance from the latest earnings call, plus robust free-cash-flow generation. Offsetting these positives are meaningful balance-sheet risk (negative equity and elevated leverage) and weak near-term technical momentum (negative MACD and price below key moving averages). Valuation is neutral-to-slightly-stretched with a modest dividend yield.
To see Spark’s full report on CAH stock, click here.
More about Cardinal Health
Cardinal Health Inc. is a U.S.-based healthcare services and products company, operating primarily in pharmaceutical distribution and medical products and distribution. Through its Pharmaceutical and Specialty Solutions segment and Global Medical Products and Distribution segment, it focuses on branded and specialty pharmaceuticals, generics programs and Cardinal Health-branded medical products for healthcare providers and systems.
Average Trading Volume: 1,719,392
Technical Sentiment Signal: Buy
Current Market Cap: $47.73B
For detailed information about CAH stock, go to TipRanks’ Stock Analysis page.